Vor Bio (VOR): Rega marang dodolan

Simbol lan logo merek Vor Biopharma, Inc. (VOR)

Vor Biopharma Inc. relies on third-party manufacturers for drug production and testing, creating a strong dependency on contractors. The P/S multiple trend on GURU.Markets demonstrates market expectations, where reflects the latest value of the metric. This is critical amid the fierce competition for leadership in cell therapy. Meanwhile, the business is shielded from macroeconomic crises due to the autonomy of its product cycles.

VOR: Kapitalisasi marang pendapatan vorbio.com 04.07.2022 - 13.11.2026

Rincian analitis perusahaan Vor Bio (VOR)

- rega saiki lan proyeksi nilai saham:
Bagan rega vorbio.com|VOR - Bagan rega target
- data kapitalisasi bursa:
Nilai pasar Vor Bio|VOR - Nilai Total Perusahaan
- data nilai buku modal saham:
Nilai Akuntansi Saham Vor Biopharma|VOR - Aset Bersih Perusahaan|Nilai Pasar marang Nilai Buku vorbio.com|VOR - Total Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Vor Biopharma Inc.|VOR - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Vor Bio Inc.|VOR - Utang perusahaan|Utang-utang marang nilai buku Vor Bio|VOR - Utang jangka dawa perusahaan|Kewajiban jangka cendhak Vor Biopharma|Rasio jangkoan perantara vorbio.com
- informasi bathi lan kelipatan valuasi:
VOR - Bathi resik|Proyeksi bathi mangsa ngarep Vor Biopharma Inc.|VOR - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi Vor Biopharma, Inc.|VOR - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Vor Bio|VOR - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Vor Biopharma|VOR - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan vorbio.com|VOR - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Vor Biopharma Inc.
- indikator pendapatan dodolan lan penghasilan bisnis:
VOR - Pendapatan perusahaan|Prakiraan pendapatan perusahaan vorbio.com|VOR - Multiplikator P/S|Multiplikator forward rega marang pendapatan Vor Bio
Analisis fundamental perusahaan:VOR - vorbio.com
Sampel barang Vor Biopharma Inc.

The P/S ratio measures a company's market value relative to its annual revenue, reflecting the extent to which an issuer's earnings are overvalued or undervalued in the eyes of investors. Analyzing the historical P/S trend allows for portfolio stress-testing by assessing the premium the market assigns to Vor Biopharma Inc. (VOR) and its breakthrough developments in genetic modification of stem cells to protect immunity during cancer therapy.

Pesaing Vor Biopharma Inc.

Rasio rega marang pendapatan TGTX (tgtherapeutics.com)|Rasio rega marang pendapatan Arcellx, Inc. ACLX|Disc Medicine Inc (IRON) - Rega marang dodolan|SNDX - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan KURA (Kura)|ADCT (ADC Therapeutics) - Kapitalisasi marang pendapatan|Foghorn Therapeutics Inc. - Rasio kapitalisasi pasar marang pendapatan|NKTX (Nkarta Inc.) - Multiplikator P/S|Rasio rega marang pendapatan COEP|Multiplikator P/S ATNM|Koefisien rega marang pendapatan Estrella Immunopharma Corp|Rasio rega marang pendapatan CASI Pharmaceuticals, Inc. CASI|Marker Therapeutics Inc (MRKR) - Rega marang dodolan|INAB - Rasio rega marang pendapatan|Rasio rega marang dodolan ERNA|GTBP: Multiplikator P/S|Aptose Biosciences - Rasio kapitalisasi pasar marang pendapatan|BPTH (Bio-Path Holdings) - Multiplikator P/S|Multiplikator P/S meipharma.com|Rasio rega marang pendapatan Vincerx Pharma, Inc. (VINC)